Zavain Dar
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Oct 1: stock award (4,607 RXRX shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Zavain Dar reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Zavain Dar's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 |
Alerts for Zavain Dar
Use this page
How to cite
Breakaway, Zavain Dar: Director at Recursion Pharmaceuticals (RXRX), Oct 1, 2026, getbreakaway.com/insiders/zavain-dar
Journalists: email support@getbreakaway.com for the data behind this page.